TCI Wealth Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

TCI Wealth Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-138	Closed	-$4K	–	2669
2021 Q2	$4K	Buy	138 +56	+68%	+$1.1K	﹤0.01%	1679
2021 Q1	$1K	Buy	+82	New	+$1.87K	﹤0.01%	2146

TCI Wealth Advisors's TBIO Position: Q3 2021 in Review

TCI Wealth Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 138 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $4K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

TCI Wealth Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
TCI Wealth Advisors sold 138 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $4K.
TCI Wealth Advisors first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
TCI Wealth Advisors's Translate Bio, Inc. Common Stock position peaked at $4K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on TCI Wealth Advisors's 13F filing for Q3 2021, filed 29 Oct 2021.